Accumulation of damage is generally considered the cause of aging. Interventions that delay aging mobilize mechanisms that protect and repair cellular components. Consequently, research has been focused on studying the protective and homeostatic mechanisms within cells. However, in humans and other multicellular organisms, cells are surrounded by extracellular matrices (ECMs), which are important for tissue structure, function, and intercellular communication. During aging, components of the ECM become damaged through fragmentation, glycation, crosslinking, and accumulation of protein aggregation, all of which contribute to age-related pathologies. Interestingly, placing senescent cells into a young ECM rejuvenates them. Furthermore, we found that many longevity-assurances pathways reactivate de novo synthesis of ECM proteins during aging. This raises the question of what constitutes a young ECM to reverse aging or maintain health? In order to make inroads to answering this question, I suggest a systems-level approach of quantifying the matrisome or ECM compositions reflecting health, pathology, or phenotype and propose a novel term, the “matreotype,” to describe this. The matreotype is defined as the composition and modification of ECM or matrisome proteins associated with or caused by a phenotype, such as longevity, or a distinct and acute physiological state, as observed during aging or disease. Every cell type produces its unique ECM. Intriguingly, cancer-cell types can even be identified based on their unique ECM composition. Thus, the matreotype reflects cellular identity and physiological status. Defined matreotypes could be used as biomarkers or prognostic factors for disease or health status during aging with potential relevance for personalized medicine. Treatment with biologics that alter ECM-to-cell mechanotransduction might be a strategy to reverse age-associated pathologies. An understanding of how to reverse from an old to a young matreotype might point toward novel strategies to rejuvenate cells and help maintain tissue homeostasis to promote health during aging.

1.
Hynes
RO
.
The extracellular matrix: not just pretty fibrils
.
Science
.
2009
Nov
;
326
(
5957
):
1216
9
.
[PubMed]
0036-8075
2.
Bonnans
C
,
Chou
J
,
Werb
Z
.
Remodelling the extracellular matrix in development and disease
.
Nat Rev Mol Cell Biol
.
2014
Dec
;
15
(
12
):
786
801
.
[PubMed]
1471-0072
3.
Frantz
C
,
Stewart
KM
,
Weaver
VM
.
The extracellular matrix at a glance
.
J Cell Sci
.
2010
Dec
;
123
(
Pt 24
):
4195
200
.
[PubMed]
0021-9533
4.
Birch
HL
. Extracellular Matrix and Ageing; in : Biochemistry and Cell Biology of Ageing: Part I Biomedical Science. Singapore, Springer Singapore,
2019
, pp 169–190.
5.
Toyama
BH
,
Hetzer
MW
.
Protein homeostasis: live long, won’t prosper
.
Nat Rev Mol Cell Biol
.
2013
Jan
;
14
(
1
):
55
61
.
[PubMed]
1471-0072
6.
Kjaer
M
,
Langberg
H
,
Miller
BF
,
Boushel
R
,
Crameri
R
,
Koskinen
S
, et al.
Metabolic activity and collagen turnover in human tendon in response to physical activity
.
J Musculoskelet Neuronal Interact
.
2005
Mar
;
5
(
1
):
41
52
.
[PubMed]
1108-7161
7.
Fisher
GJ
,
Quan
T
,
Purohit
T
,
Shao
Y
,
Cho
MK
,
He
T
, et al.
Collagen fragmentation promotes oxidative stress and elevates matrix metalloproteinase-1 in fibroblasts in aged human skin
.
Am J Pathol
.
2009
Jan
;
174
(
1
):
101
14
.
[PubMed]
0002-9440
8.
de Magalhães
JP
,
Curado
J
,
Church
GM
.
Meta-analysis of age-related gene expression profiles identifies common signatures of aging
.
Bioinformatics
.
2009
Apr
;
25
(
7
):
875
81
.
[PubMed]
1367-4803
9.
Ewald
CY
,
Landis
JN
,
Porter Abate
J
,
Murphy
CT
,
Blackwell
TK
.
Dauer-independent insulin/IGF-1-signalling implicates collagen remodelling in longevity
.
Nature
.
2015
Mar
;
519
(
7541
):
97
101
.
[PubMed]
0028-0836
10.
Shuster
S
,
Black
MM
,
McVitie
E
.
The influence of age and sex on skin thickness, skin collagen and density
.
Br J Dermatol
.
1975
Dec
;
93
(
6
):
639
43
.
[PubMed]
0007-0963
11.
Gutiérrez-Fernández
A
,
Soria-Valles
C
,
Osorio
FG
,
Gutiérrez-Abril
J
,
Garabaya
C
,
Aguirre
A
, et al.
Loss of MT1-MMP causes cell senescence and nuclear defects which can be reversed by retinoic acid
.
EMBO J
.
2015
Jul
;
34
(
14
):
1875
88
.
[PubMed]
0261-4189
12.
Vafaie
F
,
Yin
H
,
O’Neil
C
,
Nong
Z
,
Watson
A
,
Arpino
JM
, et al.
Collagenase-resistant collagen promotes mouse aging and vascular cell senescence
.
Aging Cell
.
2014
Feb
;
13
(
1
):
121
30
.
[PubMed]
1474-9718
13.
Hernandez
L
,
Roux
KJ
,
Wong
ES
,
Mounkes
LC
,
Mutalif
R
,
Navasankari
R
, et al.
Functional coupling between the extracellular matrix and nuclear lamina by Wnt signaling in progeria
.
Dev Cell
.
2010
Sep
;
19
(
3
):
413
25
.
[PubMed]
1534-5807
14.
de la Rosa
J
,
Freije
JM
,
Cabanillas
R
,
Osorio
FG
,
Fraga
MF
,
Fernández-García
MS
, et al.
Prelamin A causes progeria through cell-extrinsic mechanisms and prevents cancer invasion
.
Nat Commun
.
2013
;
4
(
1
):
2268
.
[PubMed]
2041-1723
15.
Humphrey
JD
,
Dufresne
ER
,
Schwartz
MA
.
Mechanotransduction and extracellular matrix homeostasis
.
Nat Rev Mol Cell Biol
.
2014
Dec
;
15
(
12
):
802
12
.
[PubMed]
1471-0072
16.
Bae
EJ
,
Lee
HJ
,
Rockenstein
E
,
Ho
DH
,
Park
EB
,
Yang
NY
, et al.
Antibody-aided clearance of extracellular α-synuclein prevents cell-to-cell aggregate transmission
.
J Neurosci
.
2012
Sep
;
32
(
39
):
13454
69
.
[PubMed]
0270-6474
17.
Urushitani
M
,
Ezzi
SA
,
Julien
JP
.
Therapeutic effects of immunization with mutant superoxide dismutase in mice models of amyotrophic lateral sclerosis
.
Proc Natl Acad Sci USA
.
2007
Feb
;
104
(
7
):
2495
500
.
[PubMed]
0027-8424
18.
Selkoe
DJ
.
The cell biology of beta-amyloid precursor protein and presenilin in Alzheimer’s disease
.
Trends Cell Biol
.
1998
Nov
;
8
(
11
):
447
53
.
[PubMed]
0962-8924
19.
Erikson
GA
,
Bodian
DL
,
Rueda
M
,
Molparia
B
,
Scott
ER
,
Scott-Van Zeeland
AA
, et al.
Whole-Genome Sequencing of a Healthy Aging Cohort
.
Cell
.
2016
May
;
165
(
4
):
1002
11
.
[PubMed]
0092-8674
20.
Morikiri
Y
,
Matsuta
E
,
Inoue
H
.
The collagen-derived compound collagen tripeptide induces collagen expression and extends lifespan via a conserved p38 mitogen-activated protein kinase cascade
.
Biochem Biophys Res Commun
.
2018
Nov
;
505
(
4
):
1168
73
.
[PubMed]
0006-291X
21.
Liang
J
,
Pei
XR
,
Wang
N
,
Zhang
ZF
,
Wang
JB
,
Li
Y
.
Marine collagen peptides prepared from chum salmon (Oncorhynchus keta) skin extend the life span and inhibit spontaneous tumor incidence in Sprague-Dawley Rats
.
J Med Food
.
2010
Aug
;
13
(
4
):
757
70
.
[PubMed]
1096-620X
22.
Liang
J
,
Pei
X
,
Zhang
Z
,
Wang
N
,
Wang
J
,
Li
Y
.
The protective effects of long-term oral administration of marine collagen hydrolysate from chum salmon on collagen matrix homeostasis in the chronological aged skin of Sprague-Dawley male rats
.
J Food Sci
.
2010
Oct
;
75
(
8
):
H230
8
.
[PubMed]
0022-1147
23.
Tsuruoka
N
,
Yamato
R
,
Sakai
Y
,
Yoshitake
Y
,
Yonekura
H
.
Promotion by collagen tripeptide of type I collagen gene expression in human osteoblastic cells and fracture healing of rat femur
.
Biosci Biotechnol Biochem
.
2007
Nov
;
71
(
11
):
2680
7
.
[PubMed]
0916-8451
24.
Choi
HR
,
Cho
KA
,
Kang
HT
,
Lee
JB
,
Kaeberlein
M
,
Suh
Y
, et al.
Restoration of senescent human diploid fibroblasts by modulation of the extracellular matrix
.
Aging Cell
.
2011
Feb
;
10
(
1
):
148
57
.
[PubMed]
1474-9718
25.
Sun
Y
,
Li
W
,
Lu
Z
,
Chen
R
,
Ling
J
,
Ran
Q
, et al.
Rescuing replication and osteogenesis of aged mesenchymal stem cells by exposure to a young extracellular matrix
.
FASEB J
.
2011
May
;
25
(
5
):
1474
85
.
[PubMed]
0892-6638
26.
Hendrix
MJ
,
Seftor
EA
,
Seftor
RE
,
Kasemeier-Kulesa
J
,
Kulesa
PM
,
Postovit
LM
.
Reprogramming metastatic tumour cells with embryonic microenvironments
.
Nat Rev Cancer
.
2007
Apr
;
7
(
4
):
246
55
.
[PubMed]
1474-175X
27.
Carlson
BM
,
Faulkner
JA
.
Muscle transplantation between young and old rats: age of host determines recovery
.
Am J Physiol
.
1989
Jun
;
256
(
6 Pt 1
):
C1262
6
.
[PubMed]
0002-9513
28.
Carlson
BM
,
Dedkov
EI
,
Borisov
AB
,
Faulkner
JA
.
Skeletal muscle regeneration in very old rats
.
J Gerontol A Biol Sci Med Sci
.
2001
May
;
56
(
5
):
B224
33
.
[PubMed]
1079-5006
29.
Castellano
JM
,
Mosher
KI
,
Abbey
RJ
,
McBride
AA
,
James
ML
,
Berdnik
D
, et al.
Human umbilical cord plasma proteins revitalize hippocampal function in aged mice
.
Nature
.
2017
Apr
;
544
(
7651
):
488
92
.
[PubMed]
0028-0836
30.
Naba
A
,
Clauser
KR
,
Ding
H
,
Whittaker
CA
,
Carr
SA
,
Hynes
RO
.
The extracellular matrix: tools and insights for the “omics” era
.
Matrix Biol
.
2016
Jan
;
49
:
10
24
.
[PubMed]
0945-053X
31.
Teuscher
AC
,
Jongsma
E
,
Davis
MN
,
Statzer
C
,
Gebauer
JM
,
Naba
A
, et al.
:
The in-silico characterization of the Caenorhabditis elegans matrisome and proposal of a novel collagen classification.
Matrix Biology Plus
2019
Mar 11;:1–13.
32.
Aebersold
R
,
Mann
M
.
Mass-spectrometric exploration of proteome structure and function
.
Nature
.
2016
Sep
;
537
(
7620
):
347
55
.
[PubMed]
0028-0836
33.
Naba
A
,
Clauser
KR
,
Hynes
RO
.
Enrichment of Extracellular Matrix Proteins from Tissues and Digestion into Peptides for Mass Spectrometry Analysis
.
J Vis Exp
.
2015
Jul
;
•••
(
101
):
e53057
.
[PubMed]
1940-087X
34.
Röst
HL
,
Rosenberger
G
,
Navarro
P
,
Gillet
L
,
Miladinović
SM
,
Schubert
OT
, et al.
OpenSWATH enables automated, targeted analysis of data-independent acquisition MS data
.
Nat Biotechnol
.
2014
Mar
;
32
(
3
):
219
23
.
[PubMed]
1087-0156
35.
Wick
G
,
Grundtman
C
,
Mayerl
C
,
Wimpissinger
TF
,
Feichtinger
J
,
Zelger
B
, et al.
The immunology of fibrosis
.
Annu Rev Immunol
.
2013
;
31
(
1
):
107
35
.
[PubMed]
0732-0582
36.
Teuscher
AC
,
Statzer
C
,
Pantasis
S
,
Bordoli
MR
,
Ewald
CY
.
Assessing Collagen Deposition During Aging in Mammalian Tissue and in Caenorhabditis elegans
.
Methods Mol Biol
.
2019
;
1944
:
169
88
.
[PubMed]
1064-3745
37.
Teuscher
AC
,
Ewald
CY
.
Overcoming Autofluorescence to Assess GFP Expression During Normal Physiology and Aging in Caenorhabditis elegans
.
Bio Protoc
.
2018
Jul
;
8
(
14
):
e2940
.
[PubMed]
2331-8325
38.
Budovskaya
YV
,
Wu
K
,
Southworth
LK
,
Jiang
M
,
Tedesco
P
,
Johnson
TE
, et al.
An elt-3/elt-5/elt-6 GATA transcription circuit guides aging in C. elegans
.
Cell
.
2008
Jul
;
134
(
2
):
291
303
.
[PubMed]
0092-8674
39.
Mayorca-Guiliani
AE
,
Madsen
CD
,
Cox
TR
,
Horton
ER
,
Venning
FA
,
Erler
JT
.
ISDoT: in situ decellularization of tissues for high-resolution imaging and proteomic analysis of native extracellular matrix
.
Nat Med
.
2017
Jul
;
23
(
7
):
890
8
.
[PubMed]
1078-8956
40.
Ewald
CY
,
Castillo-Quan
JI
,
Blackwell
TK
.
Untangling Longevity, Dauer, and Healthspan in Caenorhabditis elegans Insulin/IGF-1-Signalling
.
Gerontology
.
2018
;
64
(
1
):
96
104
.
[PubMed]
0304-324X
41.
Pu
YZ
,
Wan
QL
,
Ding
AJ
,
Luo
HR
,
Wu
GS
.
Quantitative proteomics analysis of Caenorhabditis elegans upon germ cell loss
.
J Proteomics
.
2017
Mar
;
156
:
85
93
.
[PubMed]
1874-3919
42.
Socovich
AM
,
Naba
A
.
The cancer matrisome: from comprehensive characterization to biomarker discovery
.
Semin Cell Dev Biol
.
2019
May
;
89
:
157
66
.
[PubMed]
1084-9521
43.
Lampi
MC
,
Reinhart-King
CA
.
Targeting extracellular matrix stiffness to attenuate disease: from molecular mechanisms to clinical trials
.
Sci Transl Med
.
2018
Jan
;
10
(
422
):
eaao0475
.
[PubMed]
1946-6234
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.